Skip to content
AnalystLens

LDOS · Leidos Holdings

50 filings

10-Q

LDOS 10-Q Quarterly Reports

Leidos Holdings - 50 quarterly reports

Filing record · 2016–202610-K1210-Q338-K130

LDOS filed 12 annual reports (10-K), 33 quarterly reports (10-Q) and 130 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Aug ’18Aug ’18
  2. Leadership change8-K · Oct ’20Oct ’20
  3. Leadership change8-K · Feb ’23Feb ’23
  4. Material agreement8-K · Feb ’25Feb ’25
  1. 2027-Q3

    Leidos Holdings Quarterly Report for Q3 Ended Oct 2, 2026

    Leidos Holdings, Inc. reported third-quarter fiscal 2026 revenues of $4.63 billion, up 3.6% from $4.47 billion a year earlier, and operating income of $553 million, up 3.4%. Net income attributable to common stockholders was $410 million, and diluted EPS was $3.28 versus $2.82. For the nine months, revenues rose 4.8% to $13.59 billion, but operating income fell 3.7% to $1.58 billion, and diluted EPS was $8.67 versus $8.62. Results were mixed by segment: Homeland grew sharply, helped by the Entrust acquisition, while Health revenue fell 11.7% in the quarter, with operating income down 25.9%, due to reduced managed health services volumes and lower incentive fees. The balance sheet changed meaningfully during the period. Leidos completed the approximately $2.4 billion cash acquisition of Entrust on March 27, 2026, funded partly by $1.4 billion of new senior notes. Total debt rose to $6.0 billion from $4.6 billion at fiscal year-end, and cash fell to $630 million. Goodwill increased to $7.7 billion. Nine-month operating cash flow improved to $1.62 billion from $1.26 billion, and the company returned capital through $766 million of open-market buybacks and dividends of $0.43 per share each quarter. After quarter-end, on October 5, 2026, Leidos closed the contribution of its Security Enterprise Solutions and Industrial Automation businesses into a joint venture with Altaris, retaining a 41.5% non-controlling interest. The company expects a non-operating gain of approximately $100 million in the fourth quarter, and it expects fourth-quarter revenues to be lower as a result. Total net bookings were $13.7 billion for the nine months, and total backlog stood at $49.6 billion. The filing also discloses an open Department of Justice Antitrust Division grand jury investigation, for which the company says it cannot currently estimate any potential liability.

    Nov 3, 2026
  2. 2027-Q2

    Leidos Holdings Quarterly Report for Q2 Ended Jul 3, 2026

    Leidos Holdings, Inc. reported second-quarter fiscal 2026 revenues of $4,558 million, up 7.2% from $4,253 million a year earlier, with the increase attributed to program wins and the Entrust acquisition. Operating income fell to $514 million from $571 million, and operating margin declined to 11.3% from 13.4%. Net income attributable to Leidos common stockholders was $354 million, or $2.81 per diluted share, compared with $391 million, or $3.01 per diluted share, in the prior-year quarter. For the six months, revenues were $8,958 million (up 5.4%) and diluted EPS was $5.37, versus $5.80. The company attributes the margin pressure partly to higher acquisition, integration and restructuring costs, a $23 million pension settlement loss, and higher interest expense. The balance sheet changed materially. On March 27, 2026, Leidos completed the acquisition of Entrust for a purchase price of $2.4 billion in cash, funded in part by $1.4 billion of new senior notes. Total debt rose to $6.0 billion from $4.6 billion at fiscal year-end, and cash and cash equivalents were $748 million. Goodwill increased to $7,663 million. Net cash provided by operating activities was $1,094 million for the six months, compared with $544 million a year earlier, driven mainly by working capital changes. Leidos also agreed to divest its Security Enterprise Solutions and Industrial Automation businesses into a joint venture with Altaris, retaining a 41.5% non-controlling interest. The company reported total backlog of $48.7 billion and net bookings of $4.9 billion for the quarter, and it authorized a new share repurchase program of up to 20 million shares in July 2026. The filing also flags risks. Roughly 83% of second-quarter revenues came from U.S. government contracts. The company notes that failure to pass appropriations or a continuing resolution by September 30, 2026 would result in a full or partial federal government shutdown. Leidos is cooperating with a Department of Justice Antitrust Division criminal investigation tied to a 2022 grand jury subpoena and cannot yet estimate any potential liabilities.

    Aug 4, 2026
  3. 2027-Q1

    Leidos Holdings Quarterly Report for Q1 Ended Apr 3, 2026

    Leidos Holdings, Inc. reported revenues of $4.40 billion for the three months ended April 3, 2026, up from $4.25 billion in the prior-year quarter, while operating income was $508 million compared with $530 million. Net income attributable to Leidos common stockholders was $328 million, or $2.56 per diluted share, versus $363 million, or $2.77 per diluted share, a year earlier. The quarter was shaped by the acquisition of Entrust for $2.4 billion in cash on March 27, 2026, which drove a $2.34 billion net cash outflow in investing activities, and by a $23 million pension settlement loss from the buy-out of the UK defined benefit plan. Total backlog rose to $48.37 billion from $46.30 billion, and net bookings were an estimated $3.3 billion compared with $2.1 billion a year earlier. Debt rose to $6.3 billion from $4.6 billion, reflecting $600 million and $800 million senior notes issued in March 2026, along with $300 million of commercial paper outstanding. Cash and cash equivalents fell to $457 million from $1.108 billion at January 2, 2026. Operating cash flow improved to $301 million from $58 million, mainly due to favorable working capital changes. The company also repurchased $200 million of open market shares during the quarter and paid $55 million in dividends. Looking ahead, Leidos agreed on April 14, 2026, to contribute its Security Enterprise Solutions and Industrial Automation businesses to a new joint venture with Analogic Corporation, in exchange for a 41.5% equity interest, with closing expected in the second half of fiscal 2026. The Entrust purchase price allocation is preliminary, and the company has not finalized fair values for substantially all acquired assets and liabilities. The company also disclosed an ongoing U.S. Department of Justice Antitrust Division criminal investigation, for which it says it cannot currently estimate any potential liability.

    May 5, 2026
  4. 2026-Q3

    Leidos Holdings Quarterly Report for Q3 Ended Oct 3, 2025

    Leidos Holdings, Inc. reported third-quarter fiscal 2025 results for the three months ended October 3, 2025, with revenues of $4,469 million, up from $4,190 million a year earlier, and operating income of $535 million versus $516 million. Net income attributable to Leidos common stockholders was $367 million, or $2.82 diluted EPS, compared with $364 million and $2.68 a year earlier. For the nine months, revenues were $12,967 million and operating income was $1,636 million, with diluted EPS of $8.62. The filing notes that the company's bookings were an estimated $5.9 billion for the quarter, with total backlog of $47,656 million and remaining performance obligations of $17 billion. Approximately 87% of revenues came from U.S. government contracts in both periods. Cash flow and balance sheet activity were shaped by capital allocation and debt management. Net cash provided by operating activities was $1,255 million for the nine months, helped by tax benefits from the One Big Beautiful Bill Act (OBBBA). The company acquired Kudu Dynamics for $293 million net of cash acquired, repaid $1,014 million of borrowings including a $450 million term loan prepayment in the quarter, and repurchased $639 million of stock for the nine months. Cash and cash equivalents stood at $974 million, total debt was $4.7 billion, and the company stated it was in compliance with all financial covenants. The filing also highlights several risks and open items. The U.S. federal government shut down on October 1, 2025, which the company says may reduce or delay work and payments. Active Defense Contract Audit Agency audits remain open for fiscal 2023 and later, and the company disclosed a Federal Grand Jury subpoena from a Department of Justice Antitrust Division investigation, stating it is not possible at this time to determine whether it will incur any fines or penalties. The company also reported an SEC matter it has self-reported, with timing and outcome not anticipated. Management stated that the legal matters are not expected to have a material adverse effect on financial position, results of operations or cash flows.

    Nov 4, 2025
  5. 2026-Q2

    Leidos Holdings Quarterly Report for Q2 Ended Jul 4, 2025

    Leidos Holdings, Inc. reported higher second-quarter fiscal 2025 results, with revenues of $4,253 million, up from $4,132 million a year earlier (2.9%). Operating income rose to $571 million from $475 million (20.2%), and operating margin improved to 13.4% from 11.5%. Net income attributable to Leidos common stockholders was $391 million, and diluted EPS was $3.01 versus $2.37. For the six months, revenues were $8,498 million (4.8% higher), operating income was $1,101 million (23.7% higher), and diluted EPS was $5.80 versus $4.42. The company cited program wins, managed health services volume growth, and prior-year write-downs in its UK operations not recurring. Segment operating margins were 10.0% for National Security & Digital, 24.4% for Health & Civil, 7.1% for Commercial & International, and 7.6% for Defense Systems in the quarter. Backlog was $46,210 million at July 4, 2025, up from $41,551 million a year earlier (recast to include sole-source IDIQ task orders), and remaining performance obligations were $16 billion. Net bookings were $3.9 billion in the quarter and $6.0 billion for the six months. Leidos acquired Kudu Dynamics on May 23, 2025 for preliminary consideration of about $291 million net of cash acquired. Cash and cash equivalents were $930 million, and total long-term debt was $5,104 million, up from $4,670 million at fiscal year-end, after issuing $500 million of 5.40% notes due 2032 and $500 million of 5.50% notes due 2035. Quarterly dividends were $0.40 per share. The filing also states that the One Big Beautiful Bill Act reduces expected fiscal 2025 income taxes payable by approximately $280 million and federal and state tax payments by approximately $150 million. The company disclosed an ongoing Department of Justice Antitrust Division criminal investigation linked to a 2022 grand jury subpoena and an open SEC matter, and stated it cannot estimate potential fines or liabilities.

    Aug 5, 2025
  6. 2026-Q1

    Leidos Holdings Quarterly Report for Q1 Ended Apr 4, 2025

    Leidos Holdings, Inc. reported first-quarter fiscal 2025 results for the three months ended April 4, 2025. Revenues rose to $4,245 million from $3,975 million, a 6.8% increase. Operating income grew to $530 million from $415 million, a 27.7% increase, and operating margin improved to 12.5% from 10.4%. Net income attributable to Leidos common stockholders was $363 million versus $284 million, and diluted EPS was $2.77 compared with $2.07. The filing attributes segment gains mainly to higher volumes and program wins. Health & Civil operating income rose 34.7%, and Defense Systems operating income rose 61.9%. The company recorded net contract estimate changes that favorably affected income before taxes by $30 million, or $0.17 of diluted EPS. Cash flow and capital allocation shifted during the quarter. Net cash from operations was $58 million, down from $113 million, mainly due to the timing of payroll and employee benefit payments. In February 2025, Leidos issued $1.0 billion of senior notes due 2032 and 2035 and used the proceeds to retire $500 million of notes due May 2025 and fund a $500 million accelerated share repurchase. Total debt was $5.1 billion at April 4, 2025, up from $4.7 billion, and cash and cash equivalents were $842 million. The $1.0 billion revolving facility was undrawn, and the company was in compliance with its financial covenants. Backlog totaled $46,296 million, up from $41,683 million in the prior-year period, which the company recast to include estimated sole-source IDIQ task orders. Net bookings were $2.1 billion, compared with $3.8 billion a year earlier. Remaining performance obligations were $17 billion. The company also signed a definitive agreement on March 10, 2025 to acquire a cyber company for a preliminary price of $300 million, with closing expected in the second quarter of 2025. Government exposure remains high: about 87% of revenues came from U.S. government contracts, and the filing notes that the Department of Government Efficiency has led to contract cancellations, modifications and stop-work orders. The company also disclosed an ongoing SEC inquiry and a Department of Justice Antitrust Division grand jury investigation, and it said it cannot currently estimate any resulting fines or liabilities.

    May 6, 2025
  7. 2025-Q3

    Leidos Holdings Quarterly Report for Q3 Ended Sep 27, 2024

    Leidos Holdings, Inc. reported third-quarter 2024 revenues of $4.19 billion, up from $3.92 billion in the prior-year quarter, a 6.9% increase. Operating income was $516 million, a 12.3% operating margin, compared with an operating loss of $336 million in the year-earlier quarter, which included a $599 million goodwill impairment and an $88 million asset impairment. Net income attributable to Leidos common stockholders was $364 million, or $2.68 diluted EPS, versus a loss of $399 million, or $(2.91) per diluted share, a year earlier. For the nine months, revenues rose 7.3% to $12.30 billion, operating income was $1.41 billion (11.4% operating margin), and diluted EPS was $7.13. The company reported net bookings of $8.1 billion in the quarter and $15.8 billion for the nine months, compared with $7.9 billion and $13.8 billion a year earlier. Total backlog was $40.56 billion at September 27, 2024, up from $38.04 billion, and remaining performance obligations were $16 billion. Health & Civil was the strongest segment, with a 23.4% operating margin in the quarter. Cash and cash equivalents increased to $1.19 billion from $0.78 billion at fiscal year-end 2023, and nine-month operating cash flow was $1.09 billion, compared with $0.86 billion a year earlier. Quarterly operating cash flow of $656 million was lower than the $795 million reported in the prior-year quarter. The filing also discloses an ongoing internal investigation into international operations, which the company has self-reported to the Department of Justice and the SEC, along with a separate Department of Justice Antitrust Division criminal investigation. The company states it cannot predict the timing, outcome, or possible impact of these matters. Shareholder returns included quarterly dividends of $0.38 per share and open-market share repurchases of $450 million over the nine months.

    Oct 29, 2024
  8. 2025-Q2

    Leidos Holdings Quarterly Report for Q2 Ended Jun 28, 2024

    Leidos Holdings, Inc. reported revenues of $4.13 billion for the three months ended June 28, 2024, up from $3.84 billion a year earlier, and $8.11 billion for the six months, compared with $7.54 billion. Operating income rose to $475 million for the quarter from $331 million, and to $890 million for the six months from $596 million. Net income attributable to Leidos common stockholders was $322 million for the quarter ($2.37 diluted EPS) versus $207 million ($1.50 diluted EPS) a year earlier. The filing notes that results include $39 million in write-downs on programs within the UK operations related to cost increases and schedule delays, and that the Commercial & International segment posted an operating loss of $11 million for the quarter. Bookings and backlog were strong. Net bookings were an estimated $4.0 billion for the quarter and $7.7 billion for the six months, compared with $2.9 billion and $5.9 billion a year earlier. Total backlog was $36.5 billion at June 28, 2024, versus $34.2 billion at June 30, 2023. Net cash provided by operating activities was $437 million for the six months, up from $66 million, and cash and cash equivalents stood at $823 million. Total debt was $4.7 billion, and the company repurchased $250 million of common stock in the six months while paying $104 million in dividends. The filing also discloses ongoing government matters. Leidos is conducting an internal investigation into international operations that may have violated the U.S. Foreign Corrupt Practices Act, has self-reported to the Department of Justice and the SEC, and is cooperating with both agencies. It also received a Department of Justice Antitrust Division grand jury subpoena in August 2022 related to three U.S. Government procurements, and states it cannot currently estimate any resulting fines or penalties.

    Jul 30, 2024
  9. 2025-Q1

    Leidos Holdings Quarterly Report for Q1 Ended Mar 29, 2024

    Leidos Holdings, Inc. reported first-quarter 2024 revenues of $3,975 million, up 7.5% from $3,699 million in the prior-year quarter. Operating income rose to $415 million from $265 million, lifting operating margin to 10.4% from 7.2%. Net income attributable to Leidos common stockholders was $284 million, compared with $162 million, and diluted EPS was $2.07 versus $1.17. The filing attributes the growth mainly to higher volumes and program wins, with Health & Civil the largest contributor. Health & Civil revenue grew 18.9% to $1,199 million, and its operating income more than doubled to $222 million, reflecting higher managed health services volumes and favorable business mix. The company's balance sheet and liquidity remained stable. Cash and cash equivalents were $633 million, outstanding debt was $4.7 billion, and there were no borrowings under the $1 billion revolving facility. Operating cash flow was $63 million, compared with negative $98 million a year earlier, mainly due to lower tax payments. The company returned capital through $53 million in dividends and open market repurchases of about $150 million. Total backlog was $36.6 billion, net bookings were an estimated $3.7 billion, and remaining performance obligations were $14.3 billion. The filing also discloses ongoing legal and regulatory matters. Leidos is conducting an internal investigation into international operations that may have violated the FCPA, has self-reported to the DOJ and SEC, and cannot anticipate the timing or outcome. A separate DOJ Antitrust Division grand jury subpoena relates to three U.S. government procurements, and the company states it cannot reasonably estimate potential penalties. The VirnetX Apple II patent case concluded on February 20, 2024, with no proceeds received by Leidos.

    Apr 30, 2024
  10. 2024-Q3

    Leidos Holdings Quarterly Report for Q3 Ended Sep 29, 2023

    Leidos Holdings, Inc. reported a net loss in the third quarter of fiscal 2023 (ended September 29, 2023) driven by a non-cash goodwill impairment charge of $599 million and an intangible asset impairment charge of $79 million, both tied to its Security Enterprise Solutions (SES) reporting unit within the Civil segment. Revenues grew to $3.92 billion in the quarter from $3.61 billion a year earlier, and operating results swung to a loss of $336 million from income of $281 million. For the nine months, revenues were $11.46 billion and net loss was $22 million, compared with net income of $513 million in the prior-year period. The filing states that the impairment followed reduced forecasts for SES, which was hurt by delays in airline travel infrastructure projects, and that SES's remaining goodwill is $303 million, with possible further impairments if forecasts worsen. Segment results show Defense Solutions and Health growing, with Defense Solutions quarterly revenue of $2.22 billion and Health revenue of $776 million, while Civil operating results were negative due to the impairments. Total backlog stood at $38.04 billion and net bookings were $7.9 billion in the quarter and $13.8 billion for the nine months. Debt totaled roughly $4.7 billion, cash and equivalents were $750 million, and the company refinanced its term loans in March 2023 under a new $1.0 billion term loan and $1.0 billion revolving facility maturing in March 2028. The filing also discloses ongoing uncertainty around the VirnetX/Apple patent matter, a self-reported FCPA-related internal investigation, and a DOJ Antitrust Division grand jury subpoena.

    Oct 31, 2023
  11. 2024-Q2

    Leidos Holdings Quarterly Report for Q2 Ended Jun 30, 2023

    Leidos Holdings, Inc. (LDOS) reported higher revenue and profitability for the second quarter and first half of fiscal 2023. Revenues for the three months ended June 30, 2023 were $3,838 million, up from $3,597 million a year earlier, and operating income rose to $331 million from $271 million. For the six months, revenues were $7,537 million versus $7,091 million, and operating income was $596 million versus $542 million. Net income attributable to Leidos common stockholders was $207 million for the quarter, with diluted EPS of $1.50 versus $1.24. Operating margin was 8.6% for the quarter compared with 7.5% in the prior-year quarter. Defense Solutions, Civil and Health all reported higher revenues for the quarter, and Health's operating income declined year over year due to a prior-year $28 million COVID-19 stop-work recovery. Cash flow and balance sheet activity were more mixed. Net cash provided by operating activities was $66 million for the six months, down from $138 million, reflecting higher tax payments. Total debt was $4.9 billion at June 30, 2023, unchanged from year-end. During the first quarter, Leidos issued $750 million of 5.75% senior notes due 2033 and entered into a $1.0 billion term loan facility and a $1.0 billion revolving facility, both maturing in March 2028. Cash and cash equivalents were $329 million. The company paid $0.36 per share in quarterly dividends and made no share repurchases in the second quarter. Total backlog was $34,152 million at June 30, 2023, compared with $34,722 million a year earlier, and second-quarter net bookings were $2.9 billion. Investors should note several disclosed legal and regulatory matters. The company is conducting an internal investigation into international operations that it has self-reported to the Department of Justice and the SEC, and it received a federal grand jury subpoena in connection with that matter. A separate grand jury subpoena from the Department of Justice Antitrust Division relates to three U.S. Government procurements. The company also holds a potential interest in VirnetX patent litigation proceeds, but the filing states that no assurances can be given when or if any proceeds will be received.

    Aug 1, 2023
  12. 2024-Q1

    Leidos Holdings Quarterly Report for Q1 Ended Mar 31, 2023

    Leidos Holdings, Inc. reported revenues of $3.70 billion for the three months ended March 31, 2023, up from $3.49 billion in the prior-year quarter. Operating income was $265 million compared with $271 million, and net income attributable to Leidos common stockholders was $162 million versus $175 million. Diluted earnings per share were $1.17, compared with $1.25. The filing attributes the revenue increase to program wins, higher volumes on certain programs and the Cobham Special Mission acquisition, partly offset by contract completions. Operating margin was 7.2%, compared with 7.8% a year earlier. Net bookings were an estimated $3.0 billion, down from $5.4 billion, and total backlog was $35.1 billion, including $610 million acquired through a business combination. Cash flow and liquidity shifted during the quarter. Net cash used in operating activities was $98 million, compared with $93 million of cash provided in the prior-year quarter, which the company primarily attributed to higher tax payments of $127 million tied to a Tax Cuts and Jobs Act provision and a $62 million payment for payroll taxes related to the CARES Act. The company refinanced its debt in the quarter, issuing $750 million of 5.75% senior notes due 2033 and entering a Credit Agreement with a $1.0 billion term loan and a $1.0 billion revolving facility, both maturing in March 2028. Total debt was $5.0 billion at March 31, 2023, and cash and cash equivalents were $379 million. Management stated it expects to meet liquidity needs for the next 12 months and anticipates tax cash payments to increase by $300 million in 2023. The filing also discloses ongoing government matters. The company self-reported to the Department of Justice and the SEC an internal investigation into international operations that may have violated the U.S. Foreign Corrupt Practices Act, and it received a grand jury subpoena from the Department of Justice Antitrust Division in August 2022. The company stated it cannot predict the timing or outcome of these matters. In the VirnetX matter, the Federal Circuit on March 31, 2023 vacated the District Court's judgment in the Apple II case and remanded it with instructions to dismiss as moot, and the filing states no assurances can be given that Leidos will receive any proceeds.

    May 2, 2023
  13. 2023-Q3

    Leidos Holdings Quarterly Report for Q3 Ended Sep 30, 2022

    Leidos Holdings, Inc. filed this Form 10-Q for the quarter ended September 30, 2022. Revenues for the three months ended September 30, 2022 were $3.61 billion, up from $3.48 billion, and operating income was $281 million versus $305 million a year earlier. For the nine months, revenues were $10.70 billion and operating income was $823 million, compared with $882 million in the prior-year period. Net income attributable to Leidos common stockholders was $162 million for the quarter ($1.17 diluted EPS) and $508 million for the nine months ($3.68 diluted EPS). The company attributed the operating income decline mainly to net write-downs on certain contracts, completion of contracts, additional general and administrative expenses and, for the nine months, increased amortization. Health segment operating margin fell to 13.8% for the quarter from 19.1%. Cash and cash equivalents were $807 million at September 30, 2022, and total debt was $5.0 billion. Net cash provided by operating activities was $881 million for the nine months, versus $821 million a year earlier. Backlog totaled $35.0 billion, and remaining performance obligations were $14.3 billion. The company repurchased stock under an accelerated share repurchase agreement, and it disclosed that it is cooperating with a Department of Justice and SEC investigation into conduct in its international operations, along with a separate DOJ Antitrust Division grand jury subpoena. It also noted that it expects to complete the Cobham Special Mission acquisition, which it did on October 30, 2022, for a preliminary price of approximately $196 million. The filing states that the company is subject to a potential future proceeds from its VirnetX litigation, but that no assurance can be given as to when or whether it will receive any proceeds. The company also noted that the TCJA research cost capitalization provision could increase income taxes payable and net deferred tax assets by approximately $150 million each in fiscal 2022.

    Nov 1, 2022
  14. 2023-Q2

    Leidos Holdings Quarterly Report for Q2 Ended Jul 1, 2022

    Leidos Holdings, Inc. reported revenues of $3.60 billion for the quarter ended July 1, 2022, up 4.3% from $3.45 billion a year earlier, and $7.09 billion for the six months, up 4.8% from $6.76 billion. Operating income was $271 million for the quarter, roughly flat versus $269 million, but fell to $542 million for the six months from $577 million, a 6.1% decline. Net income attributable to common stockholders was $171 million for the quarter, and diluted EPS was $1.24 versus $1.18. For the six months, diluted EPS was $2.49 versus $2.62. Operating margin was 7.5% for the quarter versus 7.8% and 7.6% for the six months versus 8.5%. Net cash provided by operating activities was $133 million for the six months, down from $256 million. The company reported $339 million of cash and cash equivalents and about $5.2 billion of outstanding debt. Segment results were mixed. Health operating income rose to $126 million for the quarter from $107 million, helped by $28 million of COVID-19 stop-work recoveries. Civil operating income fell to $38 million from $55 million, reflecting a $17 million increase in legal reserves and fees tied to an adverse arbitration ruling related to the 2016 acquisition of the IS&GS Business from Lockheed Martin. Defense Solutions revenue was $2.05 billion for the quarter and operating income was $139 million. Total backlog was $34.7 billion and remaining performance obligations were $15.1 billion as of July 1, 2022. Net bookings were an estimated $2.2 billion for the quarter. The filing also discloses an internal investigation, overseen by an independent board committee, into conduct at a portion of the international business that may have violated the U.S. Foreign Corrupt Practices Act. The company has self-reported the matter to the Department of Justice and the SEC and is cooperating, and it cannot predict the timing or outcome. On July 29, 2022, the company agreed to acquire Cobham Aviation Services Australia's Special Mission business for a preliminary purchase consideration of about $215 million.

    Aug 2, 2022
  15. 2023-Q1

    Leidos Holdings Quarterly Report for Q1 Ended Apr 1, 2022

    Leidos Holdings, Inc. reported revenues of $3.49 billion for the quarter ended April 1, 2022, up $179 million, or 5.4%, from $3.32 billion in the prior-year quarter. Growth came mainly from Health (up 10.0%) and Defense Solutions (up 4.6%). Operating income fell 12.0% to $271 million, and the operating margin declined to 7.8% from 9.3%. Net income attributable to Leidos common stockholders was $175 million, or $1.25 diluted EPS, compared with $205 million, or $1.42 diluted EPS, a year earlier. The Civil segment's operating income dropped to $43 million from $74 million, largely because of a $26 million benefit in the prior-year quarter from a legal reserve adjustment. Defense Solutions operating income fell to $133 million from $152 million, reflecting contract completions, net profit write-downs and higher amortization. Bookings were an estimated $5.4 billion, compared with $3.8 billion a year earlier. Total backlog reached $36.3 billion, of which $7.1 billion was funded, and remaining performance obligations were $15.4 billion. Operating cash flow fell to $93 million from $239 million, mainly due to lower sales of accounts receivable and the timing of customer and vendor payments. Cash and equivalents were $297 million at quarter end, and total debt was $5.1 billion. The company repurchased $526 million of stock in the quarter, including a $500 million accelerated share repurchase, and paid $0.36 per share in dividends. The filing also flags several risks. Leidos discovered in late 2021 conduct at a portion of its international operations that raised concerns under the Foreign Corrupt Practices Act. It has self-reported the matter to the Department of Justice and the SEC, and the outcome and possible impact cannot be anticipated. The VirnetX patent litigation may yield proceeds to Leidos, but no assurance of timing or amount is given. Separately, a Tax Cuts and Jobs Act provision on research cost capitalization is estimated to reduce fiscal 2022 cash from operations by approximately $150 million if it remains in effect.

    May 3, 2022
  16. 2022-Q3

    Leidos Holdings Quarterly Report for Q3 Ended Oct 1, 2021

    Leidos Holdings, Inc. reported its quarterly results for the three and nine months ended October 1, 2021 in this Form 10-Q. Revenues for the third quarter were $3.48 billion, up from $3.24 billion a year earlier, and operating income rose to $305 million from $258 million, lifting the operating margin to 8.8% from 8.0%. For the nine months, revenues were $10.25 billion (versus $9.05 billion) and operating income was $882 million (versus $699 million). Net income attributable to Leidos common stockholders was $205 million for the quarter, or $1.43 diluted EPS, compared with $163 million, or $1.13 diluted EPS, a year earlier. Health was the standout segment, with quarterly operating margin of 19.1% versus 14.4%, while Defense Solutions operating income fell 3.4% in the quarter. Backlog reached $34.69 billion at October 1, 2021, up from $31.72 billion, and net bookings were $4.7 billion for the quarter and $12.3 billion for the nine months, compared with $14.5 billion a year earlier. Cash from operations was $821 million for the nine months, down from $1.39 billion, mainly due to lower receivables sales, a prior-year payroll tax deferral and a prior-year VirnetX receipt. The company spent $622 million on acquisitions in the period, including Gibbs & Cox and 1901 Group, and it ended the quarter with $587 million of cash and $5.1 billion of debt. The company also established a $750 million commercial paper program in July 2021, and repurchased $237 million of stock in the nine months. The filing notes that COVID-19 did not have a material impact on revenues and operating income in the quarter, but it highlights new federal vaccination requirements for employees by December 8, 2021 and an uncertain outlook. It also flags a possible tax change, effective in 2022, that could materially reduce operating cash flow, and it describes the VirnetX patent award as subject to ongoing appeals with no assurance of when or if proceeds will be received.

    Nov 2, 2021
  17. 2022-Q2

    Leidos Holdings Quarterly Report for Q2 Ended Jul 2, 2021

    Leidos Holdings, Inc. reported second-quarter 2021 revenues of $3.448 billion, up from $2.914 billion in the prior-year quarter, and a 18.3% increase as stated in the filing. Operating income rose to $269 million from $249 million, and net income attributable to Leidos common stockholders was $169 million, compared with $153 million. For the six months ended July 2, 2021, revenues were $6.763 billion (up 16.5%) and operating income was $577 million, versus $441 million a year earlier. Growth was driven by program wins, net volume increases, and acquisitions, with Health segment revenue up 61.7% in the quarter. Operating cash flow was weak, however: $256 million for the six months, down from $794 million, which the filing attributes mainly to lower receivables sales, higher tax payments, and timing of customer advance payments. The balance sheet reflects the company's acquisitions and debt activity. Goodwill rose to $6.707 billion after the Gibbs & Cox and 1901 Group acquisitions, and total debt was $5.1 billion at July 2, 2021, with $380 million of short-term debt due May 2022. Cash and cash equivalents were $338 million. Total backlog was $33.5 billion, and remaining performance obligations were $14.6 billion. Net bookings fell to $3.8 billion in the quarter from $4.6 billion a year earlier. The company also established a commercial paper program of up to $750 million after the period end. The filing discloses several legal matters. A putative securities class action was filed in March 2021 relating to the SD&A Businesses acquisition, which the company believes lacks merit. The MSA joint venture settled its False Claims Act litigation in April 2021, with DoE paying MSA approximately $37 million and MSA paying the Department of Justice $3 million. Leidos may receive 25% of VirnetX proceeds, but no assurances on timing or amount are given because the Apple verdict remains subject to appeal.

    Aug 3, 2021
  18. 2022-Q1

    Leidos Holdings Quarterly Report for Q1 Ended Apr 2, 2021

    Leidos Holdings, Inc. reported first-quarter fiscal 2021 results for the three months ended April 2, 2021. Revenues rose to $3,315 million from $2,889 million, and operating income increased to $308 million from $192 million, giving an operating margin of 9.3% versus 6.6% a year earlier. Net income attributable to Leidos common stockholders was $205 million, or $1.42 diluted EPS, compared with $115 million and $0.80 in the prior-year quarter. Growth was driven by program wins, higher volumes, the Dynetics and SD&A Businesses acquisitions, and the 1901 Group acquisition completed in January 2021. Net bookings were an estimated $3.8 billion, compared with $5.5 billion in the prior-year quarter, and total backlog was $32.6 billion at April 2, 2021, up from $31.9 billion. Remaining performance obligations were $16.0 billion. Cash flow from operations was $239 million, down from $372 million, and cash and cash equivalents were $377 million. Total debt was $4.8 billion, and no borrowings were outstanding under the $750 million revolving facility. The company repurchased $100 million of common stock on the open market during the quarter. Dividends of $0.34 per share were paid. Legal matters include the MSA joint venture False Claims Act litigation, which was settled on April 5, 2021: MSA and Lockheed Martin will each pay $3 million, and DoE will pay MSA approximately $37 million under the related contract claim settlement. A putative securities class action filed March 2, 2021 relates to the SD&A Businesses acquisition, and the company says it believes the suit lacks merit. Leidos also has a 25% share of proceeds from the VirnetX patent awards, though receipt is uncertain given ongoing appeals.

    May 4, 2021
  19. 2021-Q3

    Leidos Holdings Quarterly Report for Q3 Ended Oct 2, 2020

    Leidos Holdings, Inc. reported third-quarter fiscal 2020 revenues of $3,242 million, up 14.4% from $2,835 million a year earlier, and nine-month revenues of $9,045 million, up 11.1% from $8,140 million. Operating income was $258 million for the quarter and $699 million for the nine months, with operating margins of 8.0% and 7.7%, respectively. Net income attributable to Leidos common stockholders was $163 million for the quarter ($1.13 diluted EPS) and $431 million for the nine months ($2.99 diluted EPS). The increase in revenue was primarily attributable to the acquisition of Dynetics, program wins and the acquisition of the L3Harris security detection and automation (SD&A) businesses. Nine-month results also reflected $87 million of prior-year gain on a business sale, $31 million of debt write-offs from refinancing, and an $81 million net gain on VirnetX proceeds recognized in the prior-year-comparable period. The filing states that COVID-19 reduced revenues by approximately $40 million in the quarter and $200 million for the nine months. The balance sheet expanded substantially due to acquisitions and debt financing. Total assets rose to $12,285 million from $9,367 million at January 3, 2020, goodwill increased to $6,158 million, and total debt was $4.5 billion, compared with $3.0 billion at year-end. Cash and cash equivalents were $512 million. Net cash provided by operating activities was $1,386 million for the nine months, versus $823 million in the prior-year period, and the company cited the timing of payroll payments and $85 million of VirnetX proceeds among the drivers. Subsequent to quarter end, on October 8, 2020, Leidos issued $1.0 billion of 2.30% senior notes due 2031 and used the proceeds to repay the 364-day Term Loan and part of the five-year Term Loan Facility. Bookings and backlog remained strong. Net bookings were estimated at $4.3 billion for the quarter and $14.5 billion for the nine months, and total backlog was $31.7 billion, up from $24.1 billion at January 3, 2020. Remaining performance obligations were $15.3 billion. The filing states that approximately 88% of revenues came from U.S. government contracts and 8% from international markets. Management noted that the fiscal 2021 U.S. government budget process has been delayed and a continuing resolution runs through December 11, 2020. The filing also discloses ongoing litigation, including the VirnetX Apple II retrial, in which a jury awarded VirnetX $503 million on October 30, 2020, with Leidos entitled to 25% of proceeds if received, and the MSA False Claims Act matter.

    Nov 2, 2020
  20. 2021-Q2

    Leidos Holdings Quarterly Report for Q2 Ended Jul 3, 2020

    Leidos Holdings, Inc. reported revenues of $2,914 million for the quarter ended July 3, 2020, up 6.8% from $2,728 million a year earlier, and $5,803 million for the six months, up 9.4% from $5,305 million. Operating income rose to $249 million in the quarter from $210 million, a margin of 8.5% versus 7.7%. Net income attributable to Leidos common stockholders was $153 million, or $1.06 per diluted share, compared with $136 million, or $0.93 per diluted share. For the six months, diluted EPS was $1.86 versus $2.23, and the prior-year period included an $87 million gain on the sale of the commercial cybersecurity business. The company cited an $81 million net gain from VirnetX proceeds in the quarter, which was recorded in bad debt expense and recoveries. The company's growth was driven by acquisitions and program wins. It acquired Dynetics (purchase price of $1.64 billion, net of cash acquired) in January 2020 and L3Harris' security detection and automation businesses (cash consideration of $968 million, net of cash acquired) in May 2020. Net bookings were $4.6 billion in the quarter and $10.2 billion for the six months, and total backlog reached $30.661 billion, up from $24.090 billion at January 3, 2020. Remaining performance obligations were $15.3 billion. Net cash from operating activities was $794 million for the six months, compared with $474 million a year earlier. COVID-19 reduced revenues by about $132 million and operating income by about $68 million in the quarter. Balance sheet leverage increased. Total debt rose to $5.0 billion from $3.0 billion, and cash and cash equivalents were $588 million. The company issued $1.75 billion of senior notes in May 2020, entered a $300 million 364-day term loan in June 2020, and repaid the $1.0 billion delayed-draw facility and the Dynetics bridge facility. On July 31, 2020, the Board approved early repayment of the $450 million senior notes due December 2020, to be retired in September 2020. The filing also reports that the Health segment's operating margin fell to 0.3% in the quarter from 12.2%, and that an arbitration brought by Lockheed Martin seeking $56 million in taxes was decided in the company's favor on July 16, 2020.

    Aug 4, 2020
  21. 2021-Q1

    Leidos Holdings Quarterly Report for Q1 Ended Apr 3, 2020

    Leidos Holdings, Inc. reported revenues of $2,889 million for the three months ended April 3, 2020, up 12.1% from $2,577 million in the prior-year quarter. Operating income was flat at $192 million, and the operating margin fell to 6.6% from 7.5%. Net income attributable to Leidos common stockholders declined 39.2% to $115 million from $189 million, and diluted EPS was $0.80 versus $1.29. The filing attributes the decline mainly to a $88 million gain on the sale of the commercial cybersecurity business in the prior-year quarter, $19 million of debt discount and issuance costs written off on the refinancing of term loans, and $11 million of accrued bridge loan duration fees tied to the Dynetics acquisition. The effective tax rate was 11.5%, compared with 23.2% a year earlier. The company's balance sheet changed substantially during the quarter. On January 31, 2020, Leidos completed the acquisition of Dynetics, Inc. for $1.64 billion net of cash acquired, funded by a $1.25 billion bridge facility and cash on hand. Total debt rose to $4.2 billion from $3.0 billion, and cash and cash equivalents fell to $445 million from $668 million. Goodwill increased to $5.72 billion and intangible assets to $950 million. Operating cash flow was $372 million, up from $288 million, helped in part by a sale of accounts receivable in the last month of the quarter. Management noted that it expects to meet its liquidity needs for the next 12 months. Orders and backlog improved. Net bookings were an estimated $5.5 billion, compared with $3.3 billion a year earlier, and total backlog reached $28.3 billion at April 3, 2020, up from $24.1 billion at January 3, 2020. The filing states that approximately 89% of revenues came from U.S. government contracts. It also discusses COVID-19 impacts, including $22 million of temporary reductions in Defense Solutions and $24 million of negative impacts in Civil. Subsequent to quarter end, on May 4, 2020, Leidos completed the acquisition of L3Harris' security detection and automation businesses for preliminary cash consideration of $1.0 billion, funded by a delayed-draw term loan.

    May 5, 2020
  22. 2020-Q3

    Leidos Holdings Quarterly Report for Q3 Ended Sep 27, 2019

    Leidos Holdings, Inc. reported third-quarter 2019 revenues of $2,835 million, up 10.1% from $2,575 million a year earlier, and operating income of $249 million, up 22.7% from $203 million. Net income attributable to Leidos common stockholders was $161 million, and diluted earnings per share were $1.11, compared with $0.96. For the nine months ended September 27, 2019, revenues were $8,140 million (up 7.9%), operating income was $651 million (up 16.0%), and diluted EPS was $3.33 versus $2.55. Results were helped by a $87 million pre-tax gain on the sale of the commercial cybersecurity business and the receipt of $59 million from the Greek government arbitration award. Net bookings were an estimated $5.2 billion in the quarter and $11.5 billion for the nine months, and total backlog stood at $23.9 billion at September 27, 2019, up from $20.8 billion at December 28, 2018. Cash flow and capital returns were strong. Net cash from operating activities was $823 million for the nine months, versus $664 million a year earlier. The company repurchased $430 million of stock and other items during the nine months, including two $200 million accelerated share repurchase agreements, and paid $101 million in dividends. Cash and cash equivalents were $635 million, total debt was $3.0 billion, and the $750 million revolving credit facility had no borrowings outstanding. Segment performance was mixed: Defense Solutions revenue rose to $1,354 million with operating income of $93 million, Health revenue rose to $508 million with operating income of $63 million, and Civil revenue rose to $973 million while operating income fell to $57 million, down 38.0%, due to higher bad debt expense on certain international contracts and lower net profit write-ups. The filing highlights several contingencies. A False Claims Act complaint against the MSA joint venture is pending, with a $39 million liability recorded and a $64 million reimbursement demand from the Department of Energy contested. Lockheed Martin has an arbitration claim for $56 million in taxes, which the company believes appears to be without merit, and no liability has been recorded. The company also holds a 25% interest in VirnetX patent award proceeds, but no assets have been recorded because appeals remain pending.

    Oct 29, 2019
  23. 2020-Q2

    Leidos Holdings Quarterly Report for Q2 Ended Jun 28, 2019

    Leidos Holdings, Inc. reported second-quarter 2019 revenues of $2.73 billion, up from $2.53 billion in the prior-year quarter, with operating income of $210 million versus $199 million and net income attributable to Leidos common stockholders of $136 million versus $144 million. For the six months ended June 28, 2019, revenues were $5.31 billion and net income attributable to common stockholders was $325 million, compared with $246 million a year earlier. The six-month results were boosted by an $87 million pre-tax gain on the February 2019 sale of the commercial cybersecurity business, which is recorded in Other income, net. The company describes itself as a FORTUNE 500 science, engineering and information technology company serving defense, intelligence, civil and health markets, with approximately 87% of total revenues from U.S. government contracts in the three and six months ended June 28, 2019. Total backlog was $21.70 billion at June 28, 2019, up from $20.83 billion at December 28, 2018, and net bookings were $3.0 billion for the quarter and $6.2 billion for the six months. Cash and cash equivalents rose to $660 million, and debt totaled $3.0 billion. Operating cash flow was $474 million for the six months. The quarterly dividend was raised to $0.34 per share from $0.32, effective in the third quarter of fiscal 2019. The company also adopted the new lease standard (ASU 2016-02), recording $433 million of right-of-use assets and $486 million of lease liabilities. The filing reports no material legal outcomes that are recorded as liabilities, aside from a $39 million liability tied to the MSA joint venture matter with the Department of Energy. Pending items include a False Claims Act complaint against MSA, an arbitration claim by Lockheed Martin for $56 million in taxes, and an enforcement effort against the Greek government in which the company cannot reliably estimate the outcome. The company also reports potential VirnetX proceeds, for which no assets are recorded.

    Jul 30, 2019
  24. 2020-Q1

    Leidos Holdings Quarterly Report for Q1 Ended Mar 29, 2019

    Leidos Holdings, Inc. reported revenues of $2,577 million for the quarter ended March 29, 2019, up from $2,443 million a year earlier, a 5.5% increase. Operating income rose to $192 million from $159 million, and the operating margin was 7.5% versus 6.5%. Net income attributable to Leidos common stockholders was $189 million, or $1.29 per diluted share, compared with $102 million, or $0.66 per diluted share, in the prior-year quarter. The results were boosted by an $88 million pre-tax gain, recorded in Other income, net, on the February 2019 sale of the company's commercial cybersecurity business, which generated initial proceeds of $171 million. The effective tax rate increased to 23.2% from 18.4%. The company's segment results were mixed. Defense Solutions revenue grew 6.6% to $1,267 million, but its operating income declined slightly to $89 million. Civil revenue rose 2.2% to $847 million, and Health revenue rose 8.9% to $463 million. Net bookings were an estimated $3.3 billion, compared with $2.5 billion a year earlier, and total backlog reached $21.48 billion at March 29, 2019, up from $20.83 billion at December 28, 2018. Remaining performance obligations were $11.0 billion. Approximately 87% of revenues came from U.S. government contracts. Cash flow and liquidity improved. Net cash provided by operating activities was $288 million, compared with $22 million, and cash and cash equivalents were $536 million at quarter end. The company repurchased $200 million of stock through an accelerated share repurchase agreement, and total debt was $3.0 billion. The filing also describes several contingencies, including a False Claims Act complaint against MSA, a joint venture in which Leidos holds a controlling interest, with a related liability of $39 million recorded, and a potential VirnetX-related recovery for which no assets are recorded.

    Apr 30, 2019
  25. 2019-Q3

    Leidos Holdings Quarterly Report for Q3 Ended Sep 28, 2018

    Leidos Holdings, Inc. reported third-quarter 2018 revenues of $2.575 billion, up from $2.503 billion a year earlier, and operating income of $203 million versus $151 million. Net income attributable to Leidos common stockholders was $147 million, or $0.96 diluted EPS, compared with $82 million and $0.53 in the prior-year quarter. For the nine months, revenues were $7.547 billion (down from $7.654 billion), operating income was $561 million (up from $458 million), and diluted EPS was $2.55 versus $1.65. The effective tax rate fell to 13.5% for the quarter, reflecting the Tax Act's lower federal rate and a valuation allowance release. Segment results were mixed. Defense Solutions and Civil revenues grew in the quarter, while Health revenues declined 4.3%. Civil operating income more than doubled in the quarter, helped by lower amortization and higher net profit write-ups. Total backlog rose to $20.32 billion from $17.48 billion at December 29, 2017, and net bookings were $4.6 billion for the quarter and $10.5 billion for the nine months. Cash flow from operations was $664 million for the nine months, versus $362 million a year earlier, and the company repurchased $162 million of stock in the nine months. Key risks include exposure to the Mission Support Alliance False Claims Act investigation, with a $39 million liability recorded, an arbitration over a $56 million Lockheed Martin tax indemnification claim, and an unresolved Greek government contract dispute. The company also announced the pending sale of its commercial cybersecurity business, which is classified as held for sale. Approximately 85% of revenues came from U.S. government contracts in the quarter.

    Oct 26, 2018
  26. 2019-Q2

    Leidos Holdings Quarterly Report for Q2 Ended Jun 29, 2018

    Leidos Holdings, Inc. reported second-quarter 2018 revenues of $2,529 million, down from $2,571 million a year earlier, a decrease the filing states as 1.6%. Six-month revenues were $4,972 million versus $5,151 million, a 3.5% decrease. Operating income rose to $199 million from $166 million for the quarter (up 19.9%) and to $358 million from $307 million for the six months (up 16.6%). Net income attributable to Leidos common stockholders was $144 million for the quarter versus $98 million, and diluted EPS was $0.94 versus $0.64. The filing attributes the lower effective tax rate (12.1% for the quarter versus 27.4%) mainly to the Tax Act's reduction of the U.S. federal statutory rate and certain benefits tied to the anticipated sale of the commercial cybersecurity business. Cash generation and backlog improved. Net cash provided by operating activities was $293 million for the six months versus $95 million, driven by favorable working capital timing. At June 29, 2018, the company held $303 million of cash and cash equivalents, $3.1 billion of outstanding debt, and an undrawn $750 million revolving credit facility. Total backlog was $18.3 billion ($18,334 million), up from $17,476 million at December 29, 2017. Net bookings were $3.4 billion for the quarter and $5.9 billion for the six months. Remaining performance obligations totaled $9.0 billion. The filing also discloses several open items. Leidos agreed in June 2018 to sell its commercial cybersecurity business, with $99 million of assets classified as held for sale. The company recorded a $39 million liability related to a False Claims Act investigation involving the MSA joint venture, partly covered by Lockheed Martin indemnification. A Greek government contract dispute remains unresolved, and the company cannot reliably estimate its outcome. Leidos would receive 25% of VirnetX patent proceeds, but no assets are recorded for them. The Plainfield note has been repeatedly extended. The company repurchased $100 million of stock in the six months and received board authorization for up to 20 million new shares.

    Jul 27, 2018
  27. 2019-Q1

    Leidos Holdings Quarterly Report for Q1 Ended Mar 30, 2018

    Leidos Holdings, Inc. reported first-quarter 2018 revenues of $2,443 million, down from $2,580 million a year earlier, a 5.3% decrease. The filing attributes the decline mainly to timing of revenue recognition on certain contracts, contract completions and net volume decreases, partially offset by new awards. Operating income rose to $159 million from $141 million, lifting the operating margin to 6.5% from 5.5%. Net income attributable to Leidos common stockholders was $102 million, or $0.66 per diluted share, compared with $72 million, or $0.47 per diluted share. The effective tax rate fell to 18.4% from 31.5%, which the company primarily attributed to the Tax Act's reduction of the U.S. federal statutory rate. The filing also notes that net favorable changes in contract estimates added $35 million to income before income taxes. Cash flow and balance sheet items were mixed. Net cash provided by operating activities was $22 million, compared with a use of $71 million in the prior-year quarter. Cash and cash equivalents were $215 million at March 30, 2018, and total long-term debt was $3,088 million. Total backlog was $17.6 billion, up from $17,476 million at December 29, 2017, and net bookings were an estimated $2.5 billion, compared with $1.7 billion a year earlier. Remaining performance obligations were $8.9 billion. During the quarter the company acquired Jacobs Engineering's 41% membership interest in Mission Support Alliance, LLC, raising its controlling ownership from 47% to 88%, and paid $81 million for acquisitions of businesses. The filing discloses several contingencies. A False Claims Act investigation related to the Mission Support Alliance contract is ongoing, and the company recorded a $39 million liability. Under the Separation Agreement, Lockheed Martin agreed to indemnify the company for 100% of damages between $38 million and $64 million and 50% above $64 million for claims against that joint venture. Leidos would receive 25% of the net proceeds from the VirnetX patent verdicts, but the verdicts remain subject to appeal and no assets were recorded for this matter.

    May 4, 2018
  28. 2018-Q3

    Leidos Holdings Quarterly Report for Q3 Ended Sep 29, 2017

    Leidos Holdings, Inc. reported third-quarter 2017 results for the period ended September 29, 2017, with revenues of $2,503 million for the quarter (up from $1,868 million) and $7,654 million for the nine months (up from $4,468 million). Operating income was $151 million for the quarter and $458 million for the nine months, and net income attributable to Leidos common stockholders was $82 million for the quarter and $252 million for the nine months. The increases largely reflect the Lockheed Martin IS&GS Business acquired in a Reverse Morris Trust transaction on August 16, 2016, which contributed revenues of $1,287 million in the quarter and $4,022 million in the nine months. Diluted EPS was $0.53 for the quarter and $1.65 for the nine months, compared with $0.80 and $2.13 a year earlier. Cash and cash equivalents were $287 million at September 29, 2017, and total debt was $3.1 billion, with the company prepaying $105 million of term loans during the quarter. Net cash provided by operating activities was $362 million for the nine months. Total backlog was $17.69 billion, versus $17.74 billion at December 30, 2016, and net bookings were $3.1 billion in the quarter and $7.4 billion for the nine months. Restructuring expenses for the IS&GS integration were $25 million for the nine months, with a total program expected to reach approximately $90 million through fiscal 2020. Significant contingencies include the MSA joint venture matter with a $39 million liability recorded, a Greek government contract dispute in which the arbitral award has been increased to $63 million and remains unpaid, and a VirnetX patent matter in which Leidos would receive 25% of any proceeds, with no asset recorded. The securities class action was settled for an immaterial amount paid by the insurer, subject to court approval.

    Nov 3, 2017
  29. 2018-Q2

    Leidos Holdings Quarterly Report for Q2 Ended Jun 30, 2017

    Leidos Holdings, Inc. reported revenues of $2.571 billion for the three months ended June 30, 2017, up from $1.288 billion in the prior-year quarter, and $5.151 billion for the six months, up from $2.600 billion. The increase reflects the August 2016 acquisition of the IS&GS Business of Lockheed Martin Corporation, which contributed revenues of $1,371 million in the quarter and $2,735 million in the six months. Operating income was $166 million for the quarter versus $75 million a year earlier, and operating margin was 6.5% compared with 5.8%. Net income attributable to Leidos common stockholders was $98 million for the quarter and $170 million for the six months. Diluted EPS was $0.64 for the quarter and $1.11 for the six months. Interest expense rose to $36 million in the quarter from $15 million, reflecting term loans secured in connection with the Transactions. Total backlog was $17.09 billion at June 30, 2017, down from $17.74 billion at December 30, 2016, while net bookings were an estimated $2.7 billion for the quarter and $4.4 billion for the six months. Cash and cash equivalents were $262 million, and long-term debt totaled $3.2 billion. Net cash provided by operating activities of continuing operations was $89 million for the six months. Dividends paid were $102 million for the six months. The company recorded $19 million of restructuring expenses for the six months under a program it expects to cost approximately $112 million through fiscal 2020. The purchase price allocation for the IS&GS Business remained preliminary, and a $303 million goodwill adjustment was recorded in the second quarter. The filing describes several contingencies. These include a MSA joint venture matter in which the company has a $39 million liability and a $1 million indemnification asset recorded, a securities class action pending at the U.S. Supreme Court with a decision expected by June 2018, and a Greek government contract dispute where the company has an arbitration award enforced at $63 million and where a July 27, 2017 Athens Court of Appeals decision rejected the government's position. The company is unable to reliably estimate the ultimate outcome of the Greek matter. Management states that it does not expect the securities litigation to have a material effect on its financial position.

    Aug 4, 2017
  30. 2018-Q1

    Leidos Holdings Quarterly Report for Q1 Ended Mar 31, 2017

    Leidos Holdings, Inc. reported first-quarter 2017 revenues of $2.58 billion, up from $1.31 billion in the prior-year quarter, with the filing stating a 96.6% increase. The increase was driven mainly by the August 16, 2016 Reverse Morris Trust acquisition of the Information Systems & Global Solutions business of Lockheed Martin Corporation, which was renamed Leidos Innovations Corporation. Operating income rose to $141 million from $89 million, but operating margin declined to 5.5% from 6.8%. Net income attributable to Leidos common stockholders was $72 million, or $0.47 per diluted share, compared with $53 million, or $0.72 per diluted share, a year earlier. Interest expense increased to $38 million from $14 million, reflecting the term loans used in the transaction. The balance sheet reflects the acquisition. Goodwill was $4.62 billion and intangible assets were $1.52 billion at March 31, 2017. Cash and cash equivalents fell to $206 million from $376 million, as operating cash outflows of $88 million and dividend payments of $50 million exceeded inflows. Total notes payable and long-term debt was $3.27 billion. Total backlog declined to $16.89 billion from $17.74 billion at December 30, 2016, while net bookings were an estimated $1.7 billion for the quarter. The company also completed a business reorganization into four segments (Defense Solutions, Civil, Health and Corporate) and recorded $13 million of restructuring expenses under a program the filing expects to cost approximately $166 million through fiscal 2019. The filing also discloses material legal and contract matters. These include a False Claims Act investigation related to the MSA joint venture, with a $39 million liability recorded; a pending Supreme Court review of a securities class action, for which the company says no material ultimate liability is expected; and a Greek government contract dispute, where the court increased the arbitral award to $63 million on April 13, 2017, but the customer has not yet paid it. The company has recorded $123 million of losses on that contract.

    May 5, 2017
  31. 2017-Q3

    Leidos Holdings Quarterly Report for Q3 Ended Sep 30, 2016

    Leidos Holdings, Inc. reported third-quarter 2016 revenues of $1,868 million, up from $1,302 million a year earlier (a 43.5% increase), and nine-month revenues of $4,468 million versus $3,805 million (17.4%). The increase was driven by the August 16, 2016 acquisition of Lockheed Martin's Information Systems & Global Solutions (IS&GS) Business, which contributed $620 million of revenue in the period from August 16 to September 30, 2016. Operating income was $101 million for the quarter (5.4% operating margin, versus 7.2% a year earlier) and $265 million for nine months (5.9% margin, versus 5.2%). Net income attributable to Leidos was $91 million for the quarter, or $0.80 diluted EPS, compared with $49 million and $0.67 in the prior-year quarter. The transaction was a Reverse Morris Trust in which Lockheed Martin stockholders received approximately 77 million Leidos shares, representing about 50.5% of outstanding shares after closing. Leidos paid a special cash dividend of $13.64 per share, totaling $993 million, and took on new debt, including $690 million of new term loans and $1.8 billion of assumed Splitco term loans. Total notes payable and long-term debt rose to $3,470 million at September 30, 2016, from $1,081 million at January 1, 2016, and cash and cash equivalents were $449 million. Goodwill increased to $4,874 million, and total backlog was $18,664 million, compared with $9,895 million at January 1, 2016. The filing also highlights several contingencies. Acquisition and integration costs were $44 million for the quarter and $68 million for nine months, and a restructuring program is expected to cost approximately $143 million through fiscal 2018. The company has recorded $123 million of losses on the Greek government contract, where the Supreme Court of Greece remanded an arbitral award case on September 22, 2016. A VirnetX jury awarded $302 million against Apple on September 30, 2016, but the filing states that an appeal is expected and that timing of any proceeds is uncertain.

    Nov 4, 2016
  32. 2017-Q2

    Leidos Holdings Quarterly Report for Q2 Ended Jul 1, 2016

    Leidos Holdings, Inc. and its wholly owned subsidiary Leidos, Inc. filed a combined Form 10-Q for the quarter ended July 1, 2016. Leidos Holdings reported revenues of $1,288 million for the three months ended July 1, 2016, up from $1,257 million a year earlier, and operating income of $75 million versus $64 million. Net income was $41 million, or $0.55 per diluted share, compared with $37 million and $0.50 per diluted share in the prior-year quarter. For the six months, revenues were $2,600 million and net income was $94 million. Cash and cash equivalents were $670 million at quarter end, and total debt was $1.1 billion. Acquisition and integration costs of $15 million for the quarter relate to the pending Lockheed Martin transaction. The filing centers on the Reverse Morris Trust transaction under which Leidos will combine with Lockheed Martin's Information Systems & Global Solutions business. Lockheed Martin shareholders would receive approximately 77 million Leidos shares, about 50.5% of the outstanding shares after closing, with existing Leidos stockholders retaining about 49.5%. Splitco is expected to incur about $1.8 billion of debt and make a $1.8 billion special cash payment to Lockheed Martin, and Leidos plans a special dividend of $13.64 per share. The filing states completion is expected in the latter half of 2016, subject to customary conditions, and that there can be no assurance the transactions will be consummated. Backlog stood at $8,967 million at July 1, 2016, down from $9,895 million at January 1, 2016, and net bookings were $1.0 billion for the quarter compared with $4.0 billion a year earlier. The filing also discloses contingencies, including a $123 million cumulative loss recorded on the Greek government contract, a pending appeal in the Greek arbitral award matter, and a VirnetX-related jury award that Leidos has not recorded as an asset because of expected appeals.

    Jul 29, 2016
  33. 2017-Q1

    Leidos Holdings Quarterly Report for Q1 Ended Apr 1, 2016

    Leidos Holdings, Inc. and its wholly owned subsidiary Leidos, Inc. filed a combined Form 10-Q for the quarter ended April 1, 2016. Revenues rose to $1,312 million from $1,246 million in the prior-year quarter, and operating income increased to $89 million from $38 million, with the prior year including a $40 million Plainfield asset impairment. Net income for Leidos Holdings was $49 million, or $0.66 per diluted share, compared with $41 million in the prior-year period. Cash and cash equivalents were $609 million at quarter end, and total backlog was $9.607 billion, down from $9.895 billion at January 1, 2016. The dominant item for investors is the pending Reverse Morris Trust transaction with Lockheed Martin's IS&GS business, announced January 26, 2016. Lockheed Martin shareholders would receive approximately 77 million Leidos shares, representing about 50.5% of outstanding shares after closing, with existing stockholders retaining about 49.5%. The transaction includes a special cash payment of $1.8 billion to Lockheed Martin funded by Splitco debt, a special dividend of approximately $1.03 billion to Leidos stockholders, and roughly $2.5 billion of new term loan indebtedness. Completion is expected in the latter half of 2016 and is subject to conditions including stockholder approval and receipt of tax opinions. Acquisition and integration costs were $9 million in the quarter, and the company expects significant further costs in fiscal 2016 and 2017. Legal matters remain material. The Greek government contract carries $123 million of recorded losses and an arbitral award of approximately $44 million that the customer has not satisfied and is contesting in Greek courts. The company also reports a potential share of any proceeds from the VirnetX jury award of $626 million against Apple, though no assets are recorded for this matter and an appeal is expected.

    Apr 28, 2016
  34. 2016-Q3

    Leidos Holdings Quarterly Report for Q3 Ended Oct 2, 2015

    Leidos Holdings, Inc. and its wholly owned subsidiary Leidos, Inc. filed a combined Form 10-Q for the quarter ended October 2, 2015. Revenues for the three months rose $26 million, or 2%, to $1.302 billion, and operating income rose $22 million, or 31%, to $94 million, with operating margin of 7.2% versus 5.6% a year earlier. For the nine months, revenues were $3.805 billion, down $89 million, or 2%, and the company reported net income of $127 million, compared with a net loss of $367 million in the prior-year period, which included a $486 million goodwill impairment charge in the Health and Engineering segment. The prior-year nine-month figures were affected by goodwill and asset impairments, so year-over-year comparisons on a net income basis are distorted. The company changed its fiscal year end to the Friday nearest December 31, so this report covers a nine-month year-to-date period that includes January 2015. Total backlog was $10.469 billion at October 2, 2015, up from $7.793 billion at January 30, 2015, and net bookings were $1.5 billion for the quarter and $6.4 billion for the nine months. Cash and cash equivalents were $635 million, and total notes payable and long-term debt was $1.145 billion. Cash provided by operating activities of continuing operations was $378 million for the nine months, and the company paid $71 million in dividends and repurchased $116 million of stock. Key legal and contract exposures remain. The company has recorded $123 million of losses on the Greek government contract, which is subject to an arbitral award of about $44 million that the Greek Athens Court of Appeals annulled, with enforcement and appeal efforts still uncertain. The company also recorded a total liability of $41 million for potential refunds of contract cost adjustments, and the Army released the company from its administrative agreement on October 1, 2015. The sale of Plainfield Renewable Energy closed on July 24, 2015 for about $101 million in aggregate consideration, and the former headquarters sale is expected to close in December 2015 for about $100 million.

    Oct 30, 2015
  35. 2016-Q2-A

    Leidos Holdings Quarterly Report (Amendment) for Q2 Ended Jul 3, 2015

    Leidos Holdings, Inc. and its wholly owned subsidiary Leidos, Inc. filed a combined Form 10-Q for the quarter ended July 3, 2015. Revenues for the quarter were $1,257 million, down from $1,306 million a year earlier, driven mainly by lower Overseas Contingency Operations (OCO) contract activity and a continued decline in the commercial health business. Operating income was $64 million, compared with an operating loss of $410 million in the prior-year quarter, which included a $486 million goodwill impairment. Quarterly diluted EPS from continuing operations was $0.50, versus a loss of $5.93 a year earlier. Results this quarter include a $29 million asset impairment charge tied to the planned sale of Plainfield Renewable Energy, which closed on July 24, 2015 for aggregate consideration of $101 million. Balance sheet and capital activity: cash and cash equivalents were $365 million at July 3, 2015, and notes payable and long-term debt totaled $1,129 million. The company had no borrowings under its $500 million revolving credit facility, and it reported $1,257 million... no, the filing states total stockholders' equity of $919 million for Leidos Holdings. During the quarter Leidos executed a $100 million accelerated share repurchase, retiring 2.4 million shares, and paid dividends of $0.32 per share. Net bookings were an estimated $4.0 billion for the quarter, and total backlog rose to $10,224 million from $7,470 million in April 2015 and $7,793 million at January 30, 2015. The filing also highlights ongoing risks. The Greek government contract remains in dispute, with $123 million of recorded losses and an arbitral award of about $43 million that the Greek courts have annulled and the company is appealing. The Company also disclosed DCAA audit exposure with a recorded liability of $44 million for estimated refunds to customers. The company is changing its fiscal year end to the Friday nearest December 31, with an 11-month transition period ending January 1, 2016.

    Aug 7, 2015
  36. 2016-Q2

    Leidos Holdings Quarterly Report for Q2 Ended Jul 3, 2015

    Leidos Holdings, Inc. and its wholly owned subsidiary Leidos, Inc. filed a combined Form 10-Q for the three and six months ended July 3, 2015. Revenues for the quarter were $1,257 million, down $49 million, or 4%, from $1,306 million a year earlier, mainly due to lower Overseas Contingency Operations (OCO) contract activity and a continued decline in the commercial health business. Operating income was $64 million, compared with an operating loss of $410 million in the prior-year quarter, which included a $486 million goodwill impairment charge. Quarterly diluted EPS from continuing operations was $0.50, versus a loss of $5.93 a year earlier. The current quarter also included $29 million of asset impairment charges tied to the Plainfield power plant, which was sold on July 24, 2015. The company reported net bookings of an estimated $4.0 billion for the quarter and total backlog of $10,224 million at July 3, 2015, up from $7,793 million at January 30, 2015. Management attributed part of the backlog increase to recent international awards, and noted that OCO revenues fell to 4.0% of total revenue in the first six months of 2015 from 8.4% a year earlier. Cash and cash equivalents were $365 million, and the company had $1,129 million of total notes payable and long-term debt. Cash used in financing activities of continuing operations was $206 million for the six months, including $115 million of stock repurchases, of which $100 million was an accelerated share repurchase in May 2015. The filing also discloses a fiscal year-end change: the year now ends on the Friday nearest December 31, and the upcoming Form 10-K will cover an 11-month transition period ending January 1, 2016. Ongoing matters include a $123 million cumulative loss recorded on the Greek government contract, with uncertain collection of a $43 million arbitral award, and a DCAA audit that is closely examining several long-established billing practices.

    Aug 5, 2015
  37. 2016-Q1

    Leidos Holdings Quarterly Report for Q1 Ended Apr 3, 2015

    Leidos Holdings, Inc. and its subsidiary Leidos, Inc. reported revenues of $1,246 million for the three months ended April 3, 2015, down 5% from $1,312 million a year earlier. Operating income fell to $38 million from $87 million, mainly because of $40 million of asset impairment charges tied to the agreed sale of the Plainfield biomass power plant. Diluted EPS from continuing operations was $0.31, compared with $0.57 in the prior-year quarter. Net income rose to $41 million from $37 million, helped by an $18 million income tax benefit in discontinued operations. National Security Solutions revenues fell 9% ($82 million) as overseas U.S. military drawdowns and budget pressures reduced contract activity, while Health and Engineering revenues rose 3% but swung to an operating loss of $7 million. Total backlog was $7.5 billion at April 3, 2015, down from $7.8 billion at January 30, 2015, and net bookings were approximately $891 million for the quarter. Cash and cash equivalents decreased $82 million to $377 million. Operating cash flow from continuing operations was negative $42 million, and the company paid $28 million to repurchase $29 million of notes. The company had no borrowings under its revolving credit facility, and $500 million of borrowing capacity was available. Quarterly dividends were $0.32 per share. The filing also highlights a change in fiscal year end to the Friday nearest December, with a transition report covering the 11-month period ending January 1, 2016. Legal and contingent matters remain significant, including Greek government contract losses of $123 million recorded to date, an arbitral award that the Athens Court of Appeals annulled and the company is still pursuing, a $46 million liability for potential contract cost refunds, and ongoing DCAA audits.

    May 12, 2015
  38. 2015-Q3

    Leidos Holdings Quarterly Report for Q3 Ended Oct 31, 2014

    Leidos Holdings, Inc. (filed under this name at the time; its subsidiary Leidos, Inc. is a co-registrant) reported a net loss of $367 million for the nine months ended October 31, 2014, compared with net income of $120 million in the prior-year period. The loss was driven by goodwill impairment charges of $486 million recorded in the second quarter of fiscal 2015, almost entirely in the Health and Engineering segment ($369 million in Health Solutions and $117 million in Engineering). For the three months ended October 31, 2014, the company reported net income of $34 million, or $0.46 diluted EPS, on revenues of $1.276 billion, down from $1.414 billion a year earlier. Revenues fell 10% in the quarter and 13% for the nine months, driven mainly by National Security Solutions, where the drawdown of overseas U.S. military forces and sequestration-related budget cuts were cited as primary causes. Balance sheet and liquidity were affected by the impairment, with total stockholders' equity falling to $976 million from $1.595 billion at January 31, 2014. Cash and cash equivalents were $418 million at October 31, 2014, and the company had no borrowings outstanding under its revolving credit facility, whose commitments were reduced from $750 million to $500 million. Total backlog declined to $8.3 billion from $9.3 billion at January 31, 2014. Management stated it expects operating cash flows, existing cash and borrowing capacity to meet requirements for at least the next 12 months. Other notable items include continued legal and contract exposures, such as the Greek government contract, where the company has recorded $123 million of losses and is pursuing enforcement of a $49 million arbitral award that the Athens Court of Appeals annulled in June 2014. The company also repurchased $105 million of its outstanding debt in the quarter and entered into interest rate swaps on its $450 million 4.45% notes.

    Dec 3, 2014
  39. 2015-Q3

    Leidos Holdings Quarterly Report for Q3 Ended Aug 1, 2014

    Leidos Holdings, Inc. reported a net loss of $438 million for the three months ended August 1, 2014 (second quarter of fiscal 2015), compared with net income of $42 million a year earlier. The loss was driven by $486 million of goodwill impairment charges in the Health and Engineering segment, along with a $24 million intangible asset impairment charge. Revenues fell 10% to $1,306 million for the quarter and 14% to $2,618 million for the six months, reflecting lower National Security Solutions revenue (down 9% in the quarter, tied largely to the drawdown of overseas U.S. military forces) and lower Health and Engineering revenue (down 14%). Operating results for the Health and Engineering segment were an operating loss of $482 million for the quarter. The balance sheet shows cash and cash equivalents of $358 million at August 1, 2014, down from $430 million at January 31, 2014, and goodwill fell to $1,207 million from $1,693 million. Total stockholders' equity dropped to $957 million from $1,595 million. Total backlog was $8.4 billion at August 1, 2014, compared with $8.8 billion at May 2, 2014. Net bookings were approximately $889 million for the quarter. The company received an $80 million U.S. Treasury cash grant related to its Plainfield biomass plant, which was a notable source of cash in the period. The filing also highlights ongoing risks: the revolving credit facility's available borrowing capacity was reduced to approximately $450 million, with the company expecting a further reduction to a range of $200 million to $300 million based on planned performance. The Plainfield plant had 30% availability for the fiscal year to date following an outage, and the filing describes ongoing legal matters including a Greek government contract dispute and the CityTime-related and data privacy litigation.

    Sep 9, 2014
  40. 2015-Q2

    Leidos Holdings Quarterly Report for Q2 Ended May 2, 2014

    Leidos Holdings, Inc. and its wholly owned subsidiary Leidos, Inc. filed this combined Form 10-Q for the first quarter of fiscal 2015, covering the three months ended May 2, 2014. Revenues fell to $1,320 million from $1,597 million a year earlier, a decrease of 17%. National Security Solutions revenues declined 12% to $944 million and Health and Engineering revenues declined 27% to $380 million, reflecting the drawdown of overseas U.S. military forces, sequestration-related budget pressure, and the completion of two energy design-build construction projects. Operating income rose to $89 million from $76 million, mainly because separation and restructuring expenses fell by $13 million. Net income was $37 million, versus $81 million a year earlier, as discontinued operations produced a $9 million loss compared with $41 million of income. Diluted EPS from continuing operations was $0.59, up from $0.43. Capital deployment dominated the quarter. Cash and cash equivalents fell $247 million to $183 million, driven by $212 million of share repurchases tied to accelerated share repurchase agreements and $24 million of dividends. Total backlog declined to $8.8 billion from $9.3 billion at January 31, 2014, and net bookings were approximately $857 million. The company reports $750 million of undrawn revolver capacity, though it expects that capacity to fall to about $600 million in the second quarter of fiscal 2015 based on covenant results. Total notes payable and long-term debt stood at $1,333 million. The filing also discloses several legal and contract matters that remain unresolved. These include the CityTime-related deferred prosecution agreement, the TRICARE data-privacy class action with a $3 million loss provision, an arbitral award of about $54 million on the Greek government contract that the customer has not satisfied (with $123 million of losses recorded), and a potential benefit from the VirnetX patent verdict against Apple, which the company has not recorded.

    Jun 4, 2014
  41. 2014-Q3

    Leidos Holdings Quarterly Report for Q3 Ended Nov 1, 2013

    Leidos Holdings, Inc. reported a third-quarter fiscal 2014 net loss of $3 million for the three months ended November 1, 2013, compared with net income of $112 million in the prior-year quarter. Revenues fell to $1.42 billion from $1.67 billion, and the company posted an operating loss of $7 million, driven by $43 million of bad debt expense tied to two energy design-build construction projects, $25 million of separation transaction and restructuring expenses, and a $19 million intangible asset impairment. The filing attributes the revenue decline mainly to National Security Solutions, where revenues fell $152 million on ramp-downs of contracts, overseas military drawdowns and sequestration, and to Health and Engineering, where revenues fell $100 million. For the nine months, revenues were $4.49 billion versus $4.90 billion, with net income of $120 million and diluted EPS from continuing operations of $0.31. The separation of New SAIC, completed September 27, 2013, shifted the technical services and enterprise IT business into discontinued operations. Cash and cash equivalents rose to $814 million at November 1, 2013, and total backlog was $10.0 billion. Cash dividends declared were $5.28 per share for the nine months, including the $4.00 special dividend. Leidos also flagged several risks: the Plainfield biomass plant it took ownership of in November 2013, ongoing U.S. Government budget uncertainty including sequestration, a pending Greek contract arbitration award of about $53 million that Greece is contesting, and legal matters including the TRICARE data-theft class actions and CityTime-related litigation. In December 2013 the board authorized a repurchase of up to 20 million shares and declared a quarterly dividend of $0.32 per share.

    Dec 10, 2013
  42. 2014-Q3

    Leidos Holdings Quarterly Report for Q3 Ended Aug 2, 2013

    SAIC, Inc. (filed under this name; now Leidos Holdings) and its wholly owned subsidiary Science Applications International Corporation filed this combined Form 10-Q for the quarter ended August 2, 2013. Revenues fell to $2,474 million for the three months ended August 2, 2013, down 12% from $2,826 million a year earlier, and operating income fell to $75 million from $189 million, with the decline attributed to $35 million of separation transaction expenses, a $30 million intangible asset impairment, and $32 million of unfavorable changes in contract estimates. Net income was $42 million, or $0.12 per basic share, versus $110 million a year earlier. Internal revenue contraction was 15% for the quarter, which management attributes to ramp-downs of certain contracts, drawdowns of U.S. military overseas, and U.S. Government budget tightening and sequestration. The company is preparing to separate into two public companies: a new SAIC focused on technical, engineering and enterprise IT services, and Leidos Holdings, Inc., focused on science and technology solutions in national security, engineering and health. The separation is expected in the second half of fiscal 2014 and is not assured. Cash and cash equivalents fell to $462 million from $736 million at January 31, 2013, mainly because of $424 million in dividend payments, including a $1.00 per share special dividend paid in June 2013. Total backlog declined to $15.9 billion from $16.5 billion at May 3, 2013, and net bookings were about $1.9 billion for the quarter. The filing also discloses material legal and contingent matters, including data privacy class actions over backup tapes covering about five million TRICARE patients, stockholder litigation tied to the CityTime contract, a Greek government contract on which $123 million of losses has been recorded, and a potential recovery of 25% of proceeds from a VirnetX patent verdict against Apple. The company was in compliance with its debt covenants as of August 2, 2013.

    Sep 5, 2013
  43. 2014-Q2

    Leidos Holdings Quarterly Report for Q2 Ended May 3, 2013

    SAIC, Inc. and its wholly owned subsidiary Science Applications International Corporation filed this combined Form 10-Q for the quarter ended May 3, 2013. Revenues were $2.71 billion, down from $2.76 billion a year earlier, with internal revenue contraction of 4% as the company cited the ramp down of certain National Security Solutions and Technical Services and Information Technology contracts and tighter U.S. Government budgets. Operating income fell to $142 million from $208 million, reflecting $33 million of separation transaction expenses tied to the planned spin-off of a new technical, engineering and enterprise IT services company, while diluted EPS was $0.23 versus $0.35. Net income was $81 million. The balance sheet shows cash and cash equivalents of $563 million, down from $736 million at January 31, 2013, after $111 million of cash used in operating activities and a $41 million quarterly dividend. Total backlog was $16.5 billion at May 3, 2013, versus $17.9 billion at January 31, 2013, and net bookings were approximately $1.3 billion for the quarter. A $357 million special dividend of $1.00 per share is payable June 28, 2013, which is reflected as a dividend payable on the balance sheet. The filing also details significant legal and contingent matters, including the CityTime settlement, a data privacy class action over backup tapes, stockholder litigation, a long-running Greek government contract dispute with $123 million of recorded losses, and a pending VirnetX patent award in which the company would receive 25% of proceeds if any are received. Management stated that the company expects to maintain sufficient liquidity for at least the next 12 months.

    Jun 4, 2013
  44. 2013-Q3

    Leidos Holdings Quarterly Report for Q3 Ended Oct 31, 2012

    SAIC, Inc. (now Leidos Holdings) and its wholly owned subsidiary Science Applications International Corporation filed a combined Form 10-Q for the quarter ended October 31, 2012. Revenues for the three months rose to $2.87 billion from $2.79 billion, and operating income was $193 million versus an operating loss of $20 million a year earlier, which was driven by a $232 million CityTime loss provision recorded in the prior-year period. Net income for the quarter was $112 million, or $0.33 per diluted share, compared with a net loss of $89 million a year earlier. For the nine months, revenues were $8.46 billion and net income was $339 million, or $1.00 per diluted share. Cash and cash equivalents fell to $531 million from $1.59 billion at January 31, 2012, mainly because of the $478 million cash acquisition of maxIT Healthcare Holdings, the $550 million repayment of 6.25% notes at maturity in July 2012, and dividend payments. Net bookings were about $4.8 billion for the quarter, and total backlog reached $18.6 billion at October 31, 2012. Management has announced a planned tax-free spin-off of its government technology and enterprise IT services business, expected in the latter half of calendar 2013, and subsequent to quarter-end it decided to eliminate about 700 positions with an estimated $15 million severance charge. Legal and regulatory matters remain significant. The company paid approximately $500 million under a deferred prosecution agreement related to the CityTime contract, and it faces a multidistrict data privacy class action tied to a backup tape theft involving TRICARE patient data, along with stockholder derivative and securities suits. It has recorded a $123 million loss on the Greek government contract, and the arbitration outcome is uncertain. The company also states that a jury awarded VirnetX approximately $368 million against Apple, and that SAIC would receive 25% of VirnetX's proceeds, though no assets are recorded for this and timing is uncertain.

    Dec 6, 2012
  45. 2013-Q2

    Leidos Holdings Quarterly Report for Q2 Ended Jul 31, 2012

    SAIC, Inc. and its wholly owned subsidiary Science Applications International Corporation filed this combined Form 10-Q for the quarterly period ended July 31, 2012. Revenues for the three months rose to $2.85 billion from $2.60 billion, with internal revenue growth of 8%, driven mainly by Defense Solutions and Intelligence and Cybersecurity Solutions. Operating income fell to $191 million (6.7% of revenues) from $209 million (8.1%), reflecting an $18 million net unfavorable change in contract estimates and higher indirect spending. Net income for the quarter was $110 million, compared with $178 million a year earlier, which included discontinued operations income of $66 million; diluted EPS from continuing operations held at $0.32. Liquidity declined sharply in the first half of fiscal 2013. Cash and cash equivalents fell to $756 million from $1.592 billion at January 31, 2012, mainly because of the $550 million repayment of 6.25% notes at maturity and a $500 million CityTime settlement payment, which the filing identifies as weighing on operating cash flow. Total backlog was $16.7 billion at July 31, 2012, down from $17.4 billion at April 30, 2012, and the company recorded $2.2 billion of net bookings in the quarter. The filing also discloses significant legal and regulatory exposure. It describes a deferred prosecution agreement and administrative agreement tied to the CityTime contract, data privacy class actions over the TRICARE backup tape theft, stockholder derivative and securities suits, and a Greek government contract with $123 million of recorded losses. On August 30, 2012, the board authorized a plan to spin off the government technology and enterprise IT services business, expected in the latter half of calendar 2013.

    Aug 31, 2012
  46. 2013-Q1

    Leidos Holdings Quarterly Report for Q1 Ended Apr 30, 2012

    SAIC, Inc. and its wholly owned subsidiary Science Applications International Corporation filed a combined Form 10-Q for the quarter ended April 30, 2012. Revenues rose 3% to $2.782 billion from $2.688 billion, with internal revenue growth of 2%. Operating income fell $22 million to $208 million (7.5% of revenues) from $230 million (8.6%), attributed mainly to higher indirect spending, including bid and proposal costs. Net income declined $14 million, or 11%, to $117 million, and diluted EPS was $0.35 versus $0.36. Net bookings were about $2.1 billion and total backlog was $17.4 billion, down from $18.0 billion at January 31, 2012. Cash and cash equivalents fell $425 million to $1.167 billion, driven by a $500 million cash settlement related to the CityTime program, which included a $370 million restitution payment and a $130 million penalty under a deferred prosecution agreement. Operating cash flow from continuing operations was negative $361 million, and the company also paid a $41 million quarterly dividend ($0.12 per share) and repurchased $19 million of stock. The board terminated the prior repurchase program in March 2012 and authorized a new program for up to 40 million shares. The filing also discloses significant legal and contingent exposures: seven consumer data privacy class actions tied to a backup tape theft affecting about five million TRICARE patients, six stockholder derivative suits and three securities class actions related to CityTime, a Greek government contract arbitration with $123 million of recorded losses, and government audit uncertainties. The company stated it could not reasonably estimate the range of loss for the stockholder matters.

    Jun 1, 2012
  47. 2012-Q3

    Leidos Holdings Quarterly Report for Q3 Ended Oct 31, 2011

    SAIC, Inc. and its wholly owned subsidiary Science Applications International Corporation filed a combined Form 10-Q for the quarter ended October 31, 2011. Revenues for the three months were $2.811 billion, flat versus $2.821 billion a year earlier, with internal revenue contraction of 2%. Operating income swung to a loss of $17 million from $252 million, driven primarily by a $232 million loss provision for the CityTime contract (a $52 million reduction in revenue and a $180 million SG&A charge) and a $19 million intangible asset impairment. Net income (loss) for the quarter was $(89) million, versus $173 million a year earlier, and diluted EPS from continuing operations was $(.27) versus $.41. The filing discloses a material weakness in internal control over financial reporting tied to CityTime, and management concluded disclosure controls were not effective as of October 31, 2011. The company says the CityTime matter could result in additional damages, penalties, and suspension or debarment, and that an additional loss is reasonably possible but cannot be estimated. Other significant matters include a data privacy class action and OCR investigation tied to a theft of backup tapes, an arbitration with the Greek government, and a $25 million settlement of a National Center for Critical Information Processing and Storage lawsuit. Liquidity remained solid, with $1.463 billion in cash and cash equivalents and $750 million of undrawn revolving credit capacity. Backlog reached $18.731 billion at October 31, 2011, up from $17.724 billion at July 31, 2011.

    Dec 8, 2011
  48. 2012-Q2

    Leidos Holdings Quarterly Report for Q2 Ended Jul 31, 2011

    SAIC, Inc. (now Leidos Holdings) reported revenues of $2,596 million for the three months ended July 31, 2011, down from $2,749 million a year earlier, and $5,284 million for the six months, down from $5,376 million. Operating income fell to $209 million from $272 million for the quarter, largely because the prior-year quarter included a $56 million royalty payment. Income from continuing operations decreased $45 million, or 29%, to $112 million, and diluted EPS from continuing operations was $.32 versus $.42. Net income for the quarter was $178 million, including $66 million from discontinued operations. That figure reflects the June 2011 sale of IT services components serving international oil and gas companies, which produced a preliminary pre-tax gain of $109 million. Total backlog was $17.7 billion at July 31, 2011, compared with $18.0 billion at April 30, 2011, and net bookings were approximately $2.3 billion for the quarter. The filing highlights several legal and contract exposures. The company has billed about $635 million under the CityTime contract with the City of New York, has recorded a $40 million receivable, and has not recorded a liability for the matter, which it describes as a probable loss whose amount it cannot reasonably estimate. The City has requested reimbursement of approximately $600 million. The company has recorded a $25 million liability for a proposed settlement of a Department of Justice matter over the National Center for Critical Information Processing and Storage contract, and has recorded $123 million of losses on the Greek government contract, where arbitration is scheduled for May 2012. Liquidity remained solid, with $1.336 billion in cash and cash equivalents and a $750 million undrawn revolving credit facility. Cash used in financing activities included $417 million for stock repurchases during the six months.

    Sep 2, 2011
  49. 2012-Q1

    Leidos Holdings Quarterly Report for Q1 Ended Apr 30, 2011

    SAIC, Inc. reported revenues of $2,688 million for the three months ended April 30, 2011, up from $2,627 million in the prior-year period, with operating income of $230 million versus $206 million and net income of $131 million versus $125 million. Diluted EPS from continuing operations was $.36, compared with $.32 a year earlier. Management attributed the operating income gain to strong program performance, cost management, organizational streamlining, and a $6 million gain on the sale of real estate. Interest expense rose to $28 million from $18 million, reflecting the December 2010 issuance of senior unsecured notes, and the effective tax rate increased to 37.2% from 34.0%. Cash and cash equivalents declined $85 million to $1.282 billion, mainly because $246 million was used to repurchase stock, partly offset by $154 million of operating cash flow. Total backlog was $18.0 billion at April 30, 2011, up from $17.1 billion at January 31, 2011, and net bookings were approximately $3.6 billion for the quarter. The company also entered a definitive agreement to sell certain components of its Commercial business, primarily specialized IT services to international oil and gas companies, and it will retain the related U.K. defined benefit pension plan. The filing discloses significant legal and contract exposures. The Department of Justice False Claims Act case over the National Center for Critical Information Processing and Storage contract seeks approximately $116 million in damages, with trial set for August 2011 and possible additional exposure of up to approximately $230 million. The Greek government contract carries $123 million of recorded losses, and the company has pursued $104 million in arbitration damages. The CityTime program with the City of New York is under criminal investigation, with the City withholding payment and no amount currently estimable for additional exposure. The company also changed its pension expense recognition method effective February 1, 2011, and restated prior periods as adjusted.

    Jun 3, 2011
  50. 2011-Q3

    Leidos Holdings Quarterly Report for Q3 Ended Oct 31, 2010

    SAIC, Inc. reported third-quarter fiscal 2011 results for the quarter ended October 31, 2010, with revenues of $2,869 million, up from $2,765 million a year earlier, and operating income of $258 million versus $233 million. Net income rose to $172 million from $135 million, and diluted EPS was $.46 versus $.34, helped by $18 million of after-tax gains from discontinued operations tied to the Telcordia/Telkom South Africa settlement. For the nine months, revenues were $8,348 million, operating income $738 million, and net income $486 million, including a $56 million royalty payment recognized as revenue in the second quarter. Cash and cash equivalents fell to $644 million from $861 million at January 31, 2010, as the company spent $358 million on acquisitions and $448 million on stock repurchases during the nine months. Total backlog was $16.3 billion at October 31, 2010, and net bookings were approximately $3.1 billion for the quarter. The filing highlights material legal and contract risks. The Department of Justice complaint on the National Center for Critical Information Processing and Storage contract seeks approximately $116 million in damages, with reasonably possible additional exposure of up to about $230 million, and trial is set for April 2011. The Greek government contract has $124 million of recorded losses, with an arbitration seeking over $98 million from the customer. The company also faces ongoing DCAA audits of its accounting and billing systems, for which it has recorded a $27 million liability for potential refunds. Management continues to describe its revenue recognition change, effective February 1, 2010, as immaterial in effect. It also states that a new 2010 share repurchase program of up to 40 million shares was authorized in December 2010, replacing the 2006 program.

    Dec 9, 2010